Implanet receives FDA 510(k) clearance of anterior cervical cage
Click Here to Manage Email Alerts
Key takeaways:
- Implanet has announced FDA 510(k) clearance of its Squale anterior cervical cage.
- The product has a range of implants designed for patients undergoing interbody fusion procedures.
Implanet has announced FDA 510(k) clearance of its Squale anterior cervical cage, according to a company press release.
The Squale anterior cervical cage has a range of implants to match the vertebral anatomy of patients undergoing interbody fusion procedures, according to the release.
“This new clearance demonstrates once again the full potential of the synergies offered by the range of products in the [orthopedic and spine development] portfolio and is fully in line with our strategy to revitalize our presence in the United States,” Ludovic Lastennet, CEO of Implanet, said in the release. “The Implanet America sales teams should be able to launch the marketing of this anterior cervical cage range before the summer of 2023. This is a new step for our development plan in the United States, aimed in particular at strengthening our offer in the field of spinal surgery in a market estimated at $1.35 billion,” Lastennet said.
Read more about
Click Here to Manage Email Alerts